diethylcarbamazine citrate
mavlab pty. ltd. - diethylcarbamazine citrate - unknown - diethylcarbamazine citrate carbamate-ethylcarbamate active 0.0 - active constituent
diethylpropion hydrochloride tablet, extended release diethylpropion hydrochloride tablet
h.j. harkins company, inc. - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride 75 mg - pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma, severe hypertension. (see precautions). agitated states. patients with a history of drug abuse. use in combination with other anorectic agents is contraindicated. during or within 14 days following the administration of monoamine oxidase inhibitors, hypertensive crises may result. diethylpropion hydrochloride extended release tablets, 75 mg are schedule iv controlled substances. diethylpropion hydrochloride has some chemical and pharmacologic similarities to the amphetamines and other related stimulant drugs that have been extensively abused. there have been reports of subjects becoming psychologically dependent on diethylpropion. the possibility of abuse should be kept in mind when evaluating the desirability of including a drug as part of a weight reduction program. abuse of amphetamines and related drugs may be associated with varying degrees of psychologic dep
vitapet heartworm prevention tablets 200mg
qpharma pty ltd - diethylcarbamazine citrate - oral tablet - diethylcarbamazine citrate carbamate-ethylcarbamate active 200.0 mg/tb - parasiticides - dog | bitch | castrate | puppy - heartworm - prevention of | to prevent heartworm
dimmitrol heartworm tablet 400mg
mavlab pty. ltd. - diethylcarbamazine citrate - oral tablet - diethylcarbamazine citrate carbamate-ethylcarbamate active 400.0 mg/tb - parasiticides - dog | bitch | castrate | puppy - heartworm - prevention of | to prevent heartworm
dimmitrol heartworm tablet 200mg
mavlab pty. ltd. - diethylcarbamazine citrate - oral tablet - diethylcarbamazine citrate carbamate-ethylcarbamate active 200.0 mg/tb - parasiticides - dog | bitch | castrate | puppy - heartworm - prevention of | to prevent heartworm
dimmitrol heartworm tablet 50mg
mavlab pty. ltd. - diethylcarbamazine citrate - oral tablet - diethylcarbamazine citrate carbamate-ethylcarbamate active 50.0 mg/tb - parasiticides - dog | bitch | castrate | puppy - heartworm - prevention of | to prevent heartworm
diethylpropion hydrochloride er tablet
apotheca inc. - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride 75 mg - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. the usefulness of agents of this class (see clinical pharmacology ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic
diethylpropion hydrochloride tablet
apotheca inc. - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride 25 mg - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. the usefulness of agents of this class (see clinical pharmacology ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic
diethylpropion hcl immediate-release- diethylpropion hydrochloride tablet diethylpropion hcl controlled-release- diethylpropion
physicians total care, inc. - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride 25 mg - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. the usefulness of agents of this class (see clinical pharmacology ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma, severe h
diethylpropion hydrochloride er- diethylpropion hydrochloride tablet, extended release
a-s medication solutions - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride 75 mg - diethylpropion hydrochloride extended release tablets, 75 mg are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. body mass index (bmi), kg/m2 weight (pounds) height (feet, inches) 5’0” 5’3” 5’6” 5’9” 6’0” 6’3” 140 27 25 23 21 19 18 150 29 27 24 22 20 19 160 31 28 26 24 22 20 170 33 30 28 25 23 21 180 35 32 29 27 25 23 190 37 34 31 28 26 24 200 39 36 32 30 27 25 210 41 37 34 31 29 26 220 43 39 36 33 30 28 230 45 41 37 34 31 29 240 47 43 39 36 33 30 250 49 44 40 37 34 31 th